PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629224
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629224
Indwelling Catheters Market size was valued at US$ 1,678.98 Million in 2024, expanding at a CAGR of 8.7% from 2025 to 2032.
The Indwelling Catheters Market is focused on devices designed to be inserted into the body for extended periods to drain bodily fluids, primarily used in urology, critical care, and surgical settings. Indwelling catheters are essential for managing urinary retention, incontinence, and other medical conditions. A growing global aging population, increasing prevalence of chronic diseases like diabetes and neurological disorders, and rising surgical procedures are key factors driving the market growth. According to the World Health Organization (WHO), the number of people aged 60 years or older is expected to double by 2050, increasing demand for indwelling catheters. However, concerns over catheter-related infections, such as urinary tract infections (UTIs), and the high cost of long-term catheterization pose significant challenges. Opportunities lie in the development of antimicrobial-coated catheters and bioresorbable materials to reduce infection risks and improve patient outcomes. Moreover, the expanding healthcare infrastructure in emerging economies, particularly in Asia-Pacific, presents new avenues for market growth. Increasing awareness of home healthcare options is also fueling demand for indwelling catheters.
Indwelling Catheters Market- Market Dynamics
Growing Prevalence of Peripheral Artery Disease Boosts Demand for Iliac Stents
The growing prevalence of peripheral artery disease (PAD) is significantly driving the demand for iliac stents, as these devices are essential for restoring blood flow in blocked iliac arteries. According to the World Health Organization (WHO), PAD affects over 200 million people globally, especially older adults and those with risk factors like diabetes and smoking. The American Heart Association reports that untreated PAD can lead to severe complications such as limb amputation. To address this, healthcare systems are increasingly adopting advanced iliac stent technologies, including drug-eluting and bioresorbable stents, which improve long-term outcomes and reduce restenosis rates. These technological advancements are especially important in regions with aging populations, such as North America and Europe, where the demand for effective and minimally invasive treatments is rising. Furthermore, governments are investing in cardiovascular healthcare to manage the rising burden of PAD, making iliac stents a critical component of modern vascular care.
Indwelling Catheters Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2025-2032)
Based on product type segmentation, Foley Catheters was predicted to show maximum market share in the year 2024
Based on Material segmentation, Silicone was the leading Material in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Indwelling Catheters Market is segmented based on Product Type, Material, Indication, End-User, and Region.
The market is divided into three categories based on product type: Foley Catheters, Urethral Catheters, and Suprapubic Catheters. Foley catheters lead the market due to their widespread use in hospital settings for urinary retention management. Urethral catheters follow, commonly used for short-term procedures. Suprapubic catheters are prioritized for patients requiring long-term catheterization or those with urethral complications.
The market is divided into three categories based on Material: Silicone, Latex, and Polyurethane. Silicone catheters are the most preferred due to their biocompatibility, durability, and reduced risk of infections. Latex catheters follow, offering a cost-effective option, though they are less favored due to allergic reactions. Polyurethane catheters are used for specific medical needs due to their strength and flexibility.
Indwelling Catheters Market- Geographical Insights
The Indwelling Catheters Market is witnessing substantial growth across various regions, with North America holding a dominant share due to advanced healthcare infrastructure, high healthcare spending, and a growing aging population. The United States, in particular, is a major contributor, driven by an increasing number of surgical procedures and higher demand for long-term catheterization solutions. Europe follows closely, with countries like Germany, France, and the UK focusing on improving patient care and reducing hospital stays, thereby boosting the adoption of indwelling catheters. In Asia-Pacific, the market is growing rapidly due to the rising incidence of chronic diseases, expanding healthcare access, and a large population base, particularly in countries like China and India. Government investments in healthcare and improving medical infrastructure further accelerate market expansion in this region. Latin America and Middle East & Africa are expected to experience moderate growth, driven by increased awareness of healthcare solutions and improving healthcare facilities. However, challenges like limited resources and high costs remain in these regions.
The Indwelling Catheters Market is highly competitive, with several leading companies dominating the industry. Major players such as Medtronic, Becton Dickinson, Coloplast, C.R. Bard, and ConvaTec are key contributors to the market, offering a wide range of catheter products to meet diverse medical needs. These companies focus on innovation, product development, and expanding their market presence through strategic partnerships and acquisitions. For instance, Medtronic and Becton Dickinson are leading the way with their advanced indwelling catheter solutions, designed to improve patient comfort and reduce infection risks. Coloplast has strengthened its position in the market by emphasizing the development of silicone-based, antimicrobial-coated catheters, which are gaining popularity for their reduced risk of urinary tract infections. Additionally, companies are increasingly investing in research and development to introduce bioresorbable materials and enhance the functionality of their catheters. As competition intensifies, companies are also exploring new markets in emerging regions like Asia-Pacific, where healthcare infrastructure is rapidly improving.
In April 2023, The Flume Catheter Company launched a study to gather real-world data on its innovative FLUME catheter, designed as an improved alternative to traditional Foley indwelling urinary catheters. The study aims to assess patient comfort and quality of life impacts.
In February 2023, B. Braun Melsungen AG introduced its new UroPro Guard catheter, designed to improve patient comfort and reduce the risk of infections, enhancing the quality of care for individuals requiring long-term catheterization.